These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17849829)

  • 1. Pharma on the hot seat.
    Huberfeld N
    J Health Law; 2007; 40(2):241-65. PubMed ID: 17849829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New exclusions and penalties complicate compliance programs.
    Fedor FP; Fuhrman CJ
    Healthc Financ Manage; 1998 Dec; 52(12):56-60. PubMed ID: 10338799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical manufacturers seek OIG comfort.
    Becker S
    Health Care Law Mon; 2002 Aug; ():3-6. PubMed ID: 12420396
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying barriers to billing compliance.
    Lorence DP; Ibrahim IA
    J Health Care Finance; 2003; 30(1):49-64. PubMed ID: 12967244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OIG demands transparency for physicians and staff in 2010: welcome to the modern era of compliance.
    Cascardo D
    J Med Pract Manage; 2009; 25(3):156-9. PubMed ID: 20073170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the HIPAA privacy rule to employer benefit plans and a compliance theory of statutory interpretation.
    Bennett B
    J Health Law; 2004; 37(2):225-65. PubMed ID: 15357281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A call for balancing of agency sentinel priorities.
    Eiland GW
    J Health Law; 1999; 32(4):503-14. PubMed ID: 10662437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In compliance... with HIPAA's NPI provisions--part III.
    Division of Advocacy and Health Policy
    Bull Am Coll Surg; 2006 Aug; 91(8):32-3. PubMed ID: 18557073
    [No Abstract]   [Full Text] [Related]  

  • 9. The changing landscape of pharmaceutical medicine.
    Lazarus A
    Physician Exec; 2004; 30(4):40-3. PubMed ID: 15344644
    [No Abstract]   [Full Text] [Related]  

  • 10. Finding out who's naughty and nice.
    Ballman J
    Mater Manag Health Care; 2003 Jan; 12(1):26-9. PubMed ID: 12587410
    [No Abstract]   [Full Text] [Related]  

  • 11. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements.
    Gosfield AG
    J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
    Zalesky CD
    J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIPAA compliance: the law, reality, and recommendations.
    Schoppmann MJ; Sanders DL
    J Am Coll Radiol; 2004 Oct; 1(10):728-33. PubMed ID: 17411692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPAA enforcement rule will more teeth equal bigger bite?
    Amatayakul M
    Healthc Financ Manage; 2006 May; 60(5):116, 118. PubMed ID: 16711531
    [No Abstract]   [Full Text] [Related]  

  • 16. Compliance with HIPAA security standards in U.S. Hospitals.
    Davis D; Having K
    J Healthc Inf Manag; 2006; 20(2):108-15. PubMed ID: 16669594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPAA compliance not so great? Maybe it's time to coordinate.
    Fody KW; Bagnal J
    Healthc Financ Manage; 2004 Jun; 58(6):84, 86. PubMed ID: 17883240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPAA, Sarbanes-Oxley, IRS, USPS and the states: juggling complicated U.S. regulations.
    Wright MG
    AHP J; 2009; ():30-4. PubMed ID: 19552242
    [No Abstract]   [Full Text] [Related]  

  • 19. New HIPAA complaint and enforcement procedures.
    Kroken P
    Radiol Manage; 2005; 27(3):10-1. PubMed ID: 15988866
    [No Abstract]   [Full Text] [Related]  

  • 20. Office of Inspector General (OIG) issues draft compliance program for pharmaceutical manufacturers.
    Turnbull GB
    Ostomy Wound Manage; 2002 Dec; 48(12):12-3. PubMed ID: 12508803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.